Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
175 studies found for:    lupus | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
lupus | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Effect of Metformin on Reducing Lupus Flares
Condition: Systemic Lupus Erythematosus
Interventions: Drug: metformin;   Drug: placebo
2 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
3 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
4 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
5 Recruiting Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Other: therapeutic education
6 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
7 Recruiting Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Condition: Cutaneous Lupus Erythematosus
Intervention: Device: UVA1 radiation treatment
8 Recruiting Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus (SLE);   Active Cutaneous Lupus Erythematosus (CLE)
Interventions: Drug: BIIB059;   Drug: Placebo
9 Not yet recruiting Dissemination of the Lupus Interactive Navigator
Condition: Systemic Lupus Erythematosus
Interventions: Other: LIN_NOW;   Other: LIN_WAIT
10 Not yet recruiting Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
Condition: Lupus Erythematosus
Intervention:
11 Not yet recruiting Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus
Conditions: Skin Restricted Lupus;   Psychiatric Disorders
Intervention: Biological: Biological dosage from plasma
12 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
13 Recruiting Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Other: Drug free;   Drug: HCQ;   Drug: GC+HCQ
14 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
15 Recruiting A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Interventions: Drug: Placebo;   Drug: Dapirolizumab pegol (DZP)
16 Recruiting Cutaneous Lupus Medication Experience Study
Condition: Cutaneous Lupus
Intervention: Drug: fluocinonide 0.05% cream
17 Recruiting A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: XmAb5871;   Biological: Placebo to match XmAb5871
18 Recruiting Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Brentuximab vedotin;   Drug: Placebo
19 Recruiting Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Chronic Cutaneous
Intervention: Drug: Etanercept
20 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.